Respiration-Gated X-Ray Source for Cardiac Dose Reduction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
During Accelerated Partial Breast Irradiation (APBI) using Electronic HDR (E-HDR) brachytherapy, the heart receives a higher biological dose due to the higher radiobiological effectiveness of x-radiation compared to Ir-192, despite receiving a lower physical dose, necessitating significant dose reduction to minimize cardiac damage.
Innovation Solution
An apparatus comprising a miniature X-ray source and a respiration state monitor that controls the X-ray source output, activating it only when the heart is at its maximum distance from the source, thereby minimizing the radiation dose to the heart by deactivating or reducing the X-ray source output during inhalation, when the heart is farther from the treatment area.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If a miniature X-ray source is used for E-HDR brachytherapy, then the radiation can be turned off when not needed and the dose rate can be varied, but the heart receives a higher biological dose due to the higher radiobiological effectiveness of x-radiation compared to Ir-192
Solution Approach 1:
The patent applies periodic action by gating the X-ray source activation to specific phases of the respiratory cycle. The source is activated only during exhale phases when the heart is at maximum distance from the treatment area, and deactivated during inhalation phases when the heart moves closer. This periodic on/off switching based on respiration timing reduces the cumulative biological dose to the heart while maintaining therapeutic efficacy in the target volume.
Solution Approach 2:
The patent implements dynamics by making the X-ray source activation dynamic rather than static. The source activation is continuously adjusted based on real-time respiration monitoring, transitioning between active and inactive states according to the patient's breathing cycle. This dynamic control allows optimization of the therapeutic ratio by delivering radiation only when anatomical conditions are favorable.
2Productivity
If the X-ray source is activated continuously to deliver therapeutic dose, then treatment time is reduced, but the heart receives excessive radiation exposure
Solution Approach 1:
The system uses periodic action by synchronizing X-ray source activation with the respiratory cycle phases. The source is activated during exhale phases (when heart distance is maximized) and deactivated during inhalation phases (when heart distance is minimized). This periodic gating maintains high treatment efficiency by delivering radiation during favorable anatomical windows while preventing excessive heart exposure through timed interruptions.
Solution Approach 2:
The patent applies skipping by intentionally interrupting the radiation delivery during inhalation phases when the heart is in vulnerable positions. Rather than delivering continuous radiation, the system skips delivery during high-risk temporal windows and rushes through treatment by concentrating dose delivery during safe exhale phases, maintaining overall treatment efficiency while protecting the heart.
3Object-affected harmful factors
If the respiration state monitor is used to control X-ray source output, then the radiation dose to the heart is minimized, but the treatment requires precise synchronization with the breathing cycle
Solution Approach 1:
The patent implements feedback by using the respiration state monitor to continuously track the patient's breathing cycle and providing real-time feedback signals to the X-ray source control system. The monitor detects respiratory phase (inhalation/exhale) and feeds this information back to gate the source activation accordingly. This closed-loop feedback system automates the synchronization process, reducing the complexity of manual coordination while achieving precise dose timing.
Solution Approach 2:
The respiration state monitor acts as an intermediary between the patient's breathing and the X-ray source activation. Rather than directly controlling the source based on complex imaging or manual intervention, the monitor serves as a simple intermediary that translates respiratory motion into source gating commands. This intermediary approach simplifies the overall control architecture while achieving the desired synchronization.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach effectively reduces the radiation dose to the heart by leveraging the reduced penetration and rapid switching capabilities of E-HDR, ensuring a therapeutic dose is maintained while minimizing cardiac exposure, as illustrated by the comparison with conventional HDR treatments.
Implementation Method 1
a respiration state monitor, and a control apparatus adapted to receive respiration state information from the respiration state monitor
Implementation Method 2
an X-ray source sized for insertion into a patient
Implementation Method 3
The quality of x-radiation (i.e. the energy spectrum) produced by a miniature x-ray tube is different from that produced by Ir-192 and typically has less penetration into tissue. This means that the radiation dose from the x-ray source is more heavily attenuated (absorbed) with distance
Implementation Method 4
the control apparatus being arranged to operate the X-ray source at a first output level when the respiration state monitor indicates a degree of lung inflation above a first preset threshold and operate the X-ray source at a second and lower output level when the respiration state monitor indicates a degree of lung inflation below a second preset threshold
Data Source
AI summary
During treatment by brachytherapy, radiation passes beyond the target volume and delivers radiation dose to adjacent tissue such as the lungs and, especially in the case of treatment of the left breast, to the heart. The heart is particularly vulnerable to radiation; to minimise the dose it receives in such circumstances, we propose an apparatus for treatment by brachytherapy comprising an X-ray source sized for insertion into a patient, a respiration state monitor, and a control apparatus adapted to receive respiration state information from the respiration state monitor and control the output of the X-ray source; the control apparatus being arranged to operate the X-ray source at a first output level when the respiration state monitor indicates a degree of lung inflation above a first preset threshold and operate the X-ray source at a second and lower output level when the respiration state monitor indicates a degree of lung inflation below a second preset threshold.